Abstract:This study employs single‐cell transcriptomic analysis to identify subgroups of glioblastoma‐associated macrophages. Spatial transcriptomic analysis reveals the spatial distribution of macrophages within glioblastoma tissue. In vitro experiments demonstrate that inhibition of MS4A4A reduces the immunosuppressive function of M2‐type macrophages. In vivo experiments confirm that inhibition of MS4A4A enhances the response of glioblastoma to PD‐1 immunotherapy. This study provides new theoretical bases and molecular therapeutic targets for the diagnosis and treatment of glioblastoma. Introduction Glioblastoma (GBM) remains a challenging brain tumor to treat, with limited response to PD‐1 immunotherapy due to tumor‐associated macrophages (TAMs), specifically the M2 phenotype. This study explores the potential of MS4A4A (membrane spanning four domains, subfamily A, member 4A) inhibition in driving M2 macrophage polarization toward the M1 phenotype via the ferroptosis pathway to enhance the effectiveness of immunotherapy in GBM. Methods Single‐cell RNA sequencing and spatial transcriptomic analyses were employed to characterize M2 macrophages and MS4A4A expression in GBM. In vitro studies utilizing TAM cultures, flow cytometry, and western blot validations were conducted to assess the impact of MS4A4A on the tumor immune microenvironment and M2 macrophage polarization. In vivo models, including subcutaneous and orthotopic transplantation in mice, were utilized to evaluate the effects of MS4A4A knockout and combined immune checkpoint blockade (ICB) therapy on tumor growth and response to PD‐1 immunotherapy. Results Distinct subsets of GBM‐associated macrophages were identified, with spatial distribution in tumor tissue elucidated. In vivo experiments demonstrated that inhibiting MS4A4A and combining ICB therapy effectively inhibited tumor growth, reshaped the tumor immune microenvironment by reducing M2 TAM infiltration and enhancing CD8+ T‐cell infiltration, ultimately leading to complete tumor eradication. Conclusion MS4A4A inhibition shows promise in converting M2 macrophages to M1 phenotype via ferroptosis, decreasing M2‐TAM infiltration, and enhancing GBM response to PD‐1 immunotherapy. These findings offer a novel approach to developing more effective immunotherapeutic strategies for GBM.

Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application

BMP4 Reverses Multidrug Resistance Through Modulation of BCL-2 and GDNF in Glioblastoma

Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells.

The Effect of BMP4 on Multidrug Resistance in Glioblastoma and the Mechanism Study

Effect of Bone Morphogenetic Protein 4 in the Human Brain Glioma Cell Line U251.

Effects of Adriamycin and Bone Morhogenetic Proteins 4 in Human Brain Glioma Cell Line U251 and Probable Signal Pathway

BMP4 and Temozolomide Synergize in the Majority of Patient-Derived Glioblastoma Cultures

The Relationship of Bone Morhogenetic Proteins 4 and Chemotherapy Sensitivity in Glioma

Mesenchymal Stem Cells As Therapeutic Agents and in Gene Delivery for the Treatment of Glioma

Significance of Bone Morphogenetic Protein 4 and SMAD 4 in the Diagnosis of Glioma

BMP4 induces a p21-dependent cell state shift in glioblastoma linking mesenchymal transition to senescence

BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.

Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma

The TGF-β Family in Glioblastoma

AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways

EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide

Nanomedicines Targeting Glioma Stem Cells

Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy

Abstract 2224: Next-generation Sequencing and Bioinformatics Analysis Identified Up-Regulation of TGFBI and SOX4 in Human Glioblastoma

Massively Parallel Signature Sequencing and Bioinformatics Analysis Identifies Up-Regulation of TGFBI and SOX4 in Human Glioblastoma